were included and 1.2% was found to have severe and 6.2% had mild COPD. 16.1% had only respiratory symptoms at baseline. The survey showed that the presence of obstructive lung disease was a significant predictor of earlier death in long term follow-up. This was true for current and former smokers,[r]
postprandial effects of glucose uptake, namely glycogen stores. Muscle Strength Mean training intensity was 70.2 ± 1.3 % of 1RM (range: 66 to 75 %). Exercisers gained on average 43 ± 29% of whole-body muscle strength, as compared to a 19 ± 31% loss in control subjects (P = 0.01). This analysi[r]
2005; 352(20):2049–2060. 15. Sarnak MJ, Katz R, Stehman-Breen CO, et al. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med. 2005; 142(7):497–505. 16. Mooradian AD. Digitalis. An update of clinical pharmacokinetics, therapeutic monitoring techniques and treat[r]
associated with whole-body insulin sensitivity such as CRP and pro-inflammatory cytokines [20]. A few recent studies have investigated exercise training on circulating adiponectin levels. These studies have shown that greater increases in adiponectin levels are associated with higher intensities of[r]
16. Regelson W, Loria R, Kalimi M. Hormonal intervention: "buffer hormones" or "state dependency". The role of dehydroepian-drosterone (DHEA), thyroid hormone, estrogen and hypophy-sectomy in aging. Ann N Y Acad Sci. 1988; 521: 260-73. 17. Herbert J. Neurosteroids, brain damage, and mental illness.[r]
Murray-Lyon IM. Prevalence of hepatitis B, C and D virus markers in Yemeni patients with chronic liver disease. J Med Virol 1993;40:330–333. 35. Frommel D, Tekle-Haimanot R, Berhe N, Aussel L, Verdier M, Preux PM, Denis F. A survey of antibodies to hepatitis C virus in Ethiopia. Am J Trop Med Hyg 19[r]
18. Farci P, et al. Hepatitis C virus-associated fulminant hepatic failure. N Engl J Med, 1996. 335(9): 631-4. 19. Vogt M, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med[r]
English cities: a case-control comparison of possible causal factors. BJU International 1999;84:95-8. 16. Wennerholm UB, Bergh C, Hamberger L, Lundin K, Nilsson L, Wikland M, et al. Incidence of congenital malformations in children born after ICSI. Hum Reprod 2000; 15:944-8. 17. Klip H, Verloop J, v[r]
[13-17]). We gathered 18 articles on the ERCC2 312/751 polymorphisms found through literature searches and checked their references for additional relevant studies. Of the relevant 18 studies, 2 studies appeared to be on populations already reported [14, 18, 19], leaving 15 independent studie[r]
rates (10-30 % and 20-30%, respectively) [15]. Pegylated interferons plus ribavirin (usually in reduced dose of 800 mg/day) have higher response rates than these latter two options (30-45%) [15]. The early viral kinetics in these patients is similar to unsuppressed patients with higher viral loads b[r]
Corresponding address: Jin Zhong Li, D.V.M. Ph.D., Department of Neurological Surgery, University of Virginia Health System, P. O. Box 800212, Charlottesville, Virginia 22908, USA Received: 2006.05.02; Accepted: 2006.05.31; Published: 2006.06.01 Osteogenic potentials of some recombinant human bone m[r]
genotypes 2 and 3 and 48 weeks in genotype 1 infection. Hematologic inclusion criteria included ANC > 800 cells/mL, hemoglobin > 10 g/dL and platelets > 35,000/mL. Growth factors were allowed in the management of therapy-induced cytopenias. The investigators estimated that “one[r]
H. pylori infection tests and subsequent eradication treatment, from July 2004 to October 2005. Those aged 20 to 75 years were enrolled after the informed con-sent on polymorphism genotyping. Participants who had smoked less than 100 cigarettes in their lifetime were categorized as never smokers, an[r]
genotypes 2 and 3 and 48 weeks in genotype 1 infection. Hematologic inclusion criteria included ANC > 800 cells/mL, hemoglobin > 10 g/dL and platelets > 35,000/mL. Growth factors were allowed in the management of therapy-induced cytopenias. The investigators estimated that “one[r]
and severity of disease. Am J Gastroenterol 2001; 96:2957. 10. Pagano G, Pacini G, Musso G, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association. Hepatology 2002; 35:367. 11. Marchesini G, Brizi M, Morselli-Labate AM, et al. A[r]
children receiving multiple blood transfusions. Indian J Gastroenterol 2002;21:183-184. 16. Gaeta GB, Stornaiuolo G, Precone DF, Lobello S, Chiaramonte M, Stroffolini T, Colucci G, et al. Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Ital[r]
Treatment should be individualized in patients with the following characteristics: 1 acute HCV infection; 2 coinfection with HIV; 3 under 18 years of age; 4 chronic renal disease, on or [r]
12. Stuyver L, et al. Hepatitis C virus genotyping by means of 5'-UR/core line probe assays and molecular analysis of untypeable samples. Virus Res 1995, 38: 137-57. 13. Zheng X, et al. Direct comparison of hepatitis C virus genotypes tested by INNO-LiPA HCV II and TRUGENE HCV genotyping methods. J[r]
replicating HCV RNA. Critical for the usefulness of this system was the identification of specific amino acid substitutions, i.e., cell culture-adaptive changes, that increased the efficiency of replication initiation by several orders of magnitude [9]. With the replicon system it became possible, f[r]